Artivion to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Artivion, Inc. (NYSE: AORT) announces participation in Stifel 2023 Healthcare Conference on November 15, 2023, and Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 16, 2023. Management will present at the Lotte New York Palace and host one-on-one meetings, providing insights into the company's cardiac and vascular surgery focus on aortic disease.

ATLANTA, Nov. 8, 2023 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate in two upcoming investor conferences.

Artivion's management team will present at the upcoming Stifel 2023 Healthcare Conference on Wednesday, November 15, 2023 at the Lotte New York Palace. The Company's presentation is scheduled to begin at 9:45a.m. ET. A live webcast can be accessed through Artivion's website, www.artivion.com, on the Investors page. An archived copy of the webcast will be available for 90 days on the same website.

Members of the management team will also host one-on-one meetings at the upcoming Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on Thursday, November 16, 2023. Due to the format of this event no webcast will be available.

About Artivion, Inc.
Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.artivion.com.

Contacts:
Artivion	Gilmartin Group LLC
D. Ashley Lee	Brian Johnston / Lynn Lewis
Executive Vice President &	Phone: 332-895-3222
Chief Financial Officer	investors@artivion.com
Phone: 770-419-3355

View original content to download multimedia:https://www.prnewswire.com/news-releases/artivion-to-participate-in-upcoming-investor-conferences-301982323.html

SOURCE Artivion, Inc.

FAQ

What is the event Artivion, Inc. (NYSE: AORT) will participate in on November 15, 2023?

Artivion, Inc. (NYSE: AORT) will participate in the Stifel 2023 Healthcare Conference on November 15, 2023.

Where can the live webcast of Artivion, Inc.'s presentation be accessed?

The live webcast of Artivion, Inc.'s presentation can be accessed through the company's website, www.artivion.com, on the Investors page.

For how long will an archived copy of the webcast be available?

An archived copy of the webcast will be available for 90 days on Artivion, Inc.'s website, www.artivion.com.

What is the format of the event on November 16, 2023?

Members of Artivion, Inc.'s management team will host one-on-one meetings at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 16, 2023.